Evidence map›Paper›PMID 40575717›Full record

ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025

The hidden burden: Inflammatory bowel disease and cardiovascular mortality in underreported populations.

Jose Eric M Lacsa

Abstract readLetter
In one paragraph

Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jose Eric M LacsaDe La Salle University, the Republic of the Philippines.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent data from the United States reveal a rising trend in mortality linked to inflammatory bowel disease (IBD) and cardiovascular disease (CVD), with pronounced disparities across age, sex, race, and geography. This commentary reappropriates those findings within the context of the Philippines and other low- and middle-income countries (LMICs), where chronic inflammation remains underdiagnosed and health systems are ill-equipped to address its cardiovascular consequences. While CVD is already the leading cause of death in the Philippines, the compounding effects of inflammatory disorders like IBD are largely overlooked. Drawing parallels from U.S. patterns, we highlight how rural-urban divides, healthcare inaccessibility, and poor disease surveillance may fuel similar trends in LMICs. We call for integrated screening strategies, improved chronic disease registries, and cross-disciplinary approaches that recognize inflammation as a key driver of cardiovascular risk. The global burden of cardiovascular disease cannot be fully addressed without confronting the silent role of systemic inflammation.

Indexed as

Cardiovascular mortalityGlobal health disparitiesInflammatory bowel diseaseLow- and middle-income countries (LMICs)Systemic inflammation

Identifiers

PMID40575717
PMCPMC12197874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.